At a 10-year low, here’s what the charts say for this FTSE 100 stock!

Legal troubles, compliance issues, and dismal sales have sent this FTSE 100 stock tumbling, but could a share price recovery be on the horizon?

| More on:

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Much to the delight of British investors, the FTSE 100 index is within touching distance of a new all-time high. However, not all individual FTSE 100 shares are joining the party.

Consumer goods giant Reckitt (LSE:RKT) is one Footsie company that’s having a tough time. The conglomerate, which owns household brands such as Cillit Bang, Dettol, and Durex, currently trades at levels not seen since 2012. Over the past year, the Reckitt share price has fallen 34%.

So is this a good opportunity for investors to consider buying an undervalued stock? Or could Reckitt shares plunge further from here?

Let’s explore.

Disappointing earnings

Stocks rarely fall to a 10-year low for no reason. In Reckitt’s case, a bad set of final quarter earnings precipitated a selling frenzy that shows few signs of abating.

Analysts at RBC Capital Markets branded the firm’s performance as “really grim rather than just poor“. New chief executive Kris Licht didn’t shy away from criticism, describing the results as “unsatisfactory”. These are hardly encouraging words for prospective investors to hear.

Source: TradingView

As the chart above illustrates, diluted earnings per share (EPS) slipped to 227.4p from 325.7p in 2022. This represents a 30% decline, driven by particular weakness in the nutrition division. But the bad news doesn’t end there.

Reporting anomalies in the Middle East knocked the firm’s full-year net income to the tune of £55m, damaging investor confidence. Reckitt maintains that the issue’s been isolated and it’s taking disciplinary action against some employees.

Nonetheless, I’m not particularly excited by guidance for net revenue growth of 2%-4% in 2024. There’s a significant risk that another poor quarter could send the share price tumbling further.


On the bright side, the company’s price-to-sales ratio is now at the bottom of its five-year range at just above two. Using this metric, Reckitt shares look cheaper than they’ve been for years.

Source: TradingView

However, the depressed valuation reflects the stock’s greater risk profile following an adverse legal ruling against the firm.

Last month, a US jury awarded $60m in damages to the mother of a premature baby who died of an intestinal disease after consuming Reckitt’s baby formula product Enfamil.

Potential investors should note the business may face more financial liabilities from product liability lawsuits, although it intends to challenge the verdict.

Dividend boost

One upshot of the share price fall is the rise in the firm’s dividend payouts. At 4.6%, the yield on offer today is well above what shareholders have come to expect in recent years.

Source: TradingView

Furthermore, an ongoing £1bn share buyback programme looks secure following a free cash flow improvement from £2bn to £2.3bn. This was a rare bright spot in an otherwise disappointing set of results.

What I’m doing

At first glance, Reckitt shares may appear undervalued today and the higher dividend yield looks tempting. However, it’s not enough for me to invest.

Digging into the weak earnings report, the cheaper valuation looks justified to me, especially in light of further potential legal difficulties for the business.

While Reckitt may boast an impressive product portfolio of household staples, I’d like to see that translate into concrete financial success before adding this FTSE 100 stock to my portfolio.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Charlie Carman has no position in any of the shares mentioned. The Motley Fool UK has recommended Reckitt Benckiser Group Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

Nvidia stock is becoming more affordable!

Nvidia stock is up 2,500% over five years, but the chip giant’s share split -- announced during its earnings report…

Read more »

Investing Articles

Are Rolls-Royce shares good for passive income?

Our writer is getting mixed messages about the Rolls-Royce dividend. But whatever happens, he thinks passive income hunters will be…

Read more »

Investing Articles

Could the Rolls-Royce share price end 2024 above £5?

As the Rolls-Royce share price continues its remarkable run, our writer considers where it might be at the end of…

Read more »

Investing Articles

UK stocks are hitting all-time highs! Yet these 2 still look cheap to me

The FTSE 100's on a roll. But it's still possible to pick bargain UK stocks, provided we know where to…

Read more »

Satellite on planet background
Investing Articles

At just under £14, can BAE Systems’ share price still be a prime FTSE 100 bargain? 

Despite its bullish price run, BAE Systems’ share price still looks undervalued to me and appears set for strong growth.

Read more »

Photo of a man going through financial problems
Investing Articles

2 dividend shares I’d avoid like the plague in today’s stock market

The UK stock market is full of high-yield dividend shares that could equate to a steady stream of passive income.…

Read more »

Abstract bull climbing indicators on stock chart
Investing Articles

£17,000 in savings? Here’s how I’d aim to turn that into a £29,548 annual second income!

Generating a sizeable second income can be life-enhancing and can be done from relatively small investments in high-dividend-paying stocks.

Read more »

Investing Articles

With as little as £300 a month invested, this stock could net £16,000 a year in passive income

Putting a few hundred pounds each month into the stock market could eventually generate a five-figure annual passive income, this…

Read more »